… the HSE and the manufacturers of the medication, after the suggested price of the drug was deemed too expensive by health authorities. Chloe has the gene mutation G551D, which makes her eligible for the drug. But Kalydeco is only available for …
… the HSE and the manufacturers of the medication, after the suggested price of the drug was deemed too expensive by health authorities. Chloe has the gene mutation G551D, which makes her eligible for the drug. But Kalydeco is only available for …